Highlights EVT Limited

Equities

EVT

AU000000EVT1

Market Closed - Australian S.E. Other stock markets 11:40:14 09/05/2024 am IST			5-day change	1st Jan Change
11.98 ^AUD	-1.24%		+0.93%	-2.04%

30/04	Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases	MT
24/04	Germany's Evotec Appoints Permanent CEO	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases	30/04	MT
Evotec, Variant Bio Team Up to Develop Treatment for Fibrosis	18/04	MT
Ex-dividend day for interim dividend	28/02	FA
EVT's Net Profit Declines 72% in Fiscal H1 on Thredbo Impact	15/02	MT
EVT Limited Reports Earnings Results for the Half Year Ended December 31, 2023	15/02	CI
Economic Investment Trust Limited Announces Dividend	08/02	MT
Evotec's US Unit Expands Collaboration vs HIV with Advanced BioScience Laboratories	07/02	MT
Evotec Reiterates Trading Regulations Compliance Amid Former CEO’s Late Stock Trades Disclosure	22/01	MT
Evotec Receives $25 Million Under Neuroscience Collaboration with Bristol Myers Squibb	08/01	MT
Correction: Evotec, Owkin Team Up on AI-powered Research Across Oncology, Immunology, Inflammation	04/01	MT
Evotec, Owken Team Up on AI-powered Research Across Oncology, Immunology, Inflammation	04/01	MT
Evotec Secures Grant for Teratogenicity Platform	19/12	MT
Evotec Partners With German Institution for Expanded Autoimmune Diseases Patients Database; Shares Up	14/12	MT
Evotec, Glycotope Partner on Immune Cell Bispecifics Development Against Tumor	11/12	MT
Evotec Signs Strategic Oncology-focused Partnership With Dewpoint Therapeutics	07/11	MT
EVT Limited Provides Earnings Guidance for the Full Year 2023	20/23/20	CI
Evotec Grants Three Partners Access to R&D Platform in Support of Biotech Innovation	27/23/27	MT
Evotec, Novo Nordisk Partner for Translational Drug Discovery Accelerator	26/23/26	MT
Final dividend	13/23/13	FA
EVT Limited Announces Ordinary Fully Franked Dividend for the Twelve Months Ended June 30, 2023, Payable on September 28, 2023	28/23/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights EVT Limited

Equities

EVT

AU000000EVT1

Highlights

Filters